顺铂在肠胃外水性载体中的稳定性。 - Suppr

Suppr

超能文献

Cis-platin stability in aqueous parenteral vehicles.

作者信息

Hincal A A, Long D F, Repta A J

出版信息

J Parenter Drug Assoc. 1979 May-Jun;33(3):107-16.

PMID:256991

Abstract

摘要

相似文献

Cis-platin stability in aqueous parenteral vehicles.顺铂在肠胃外水性载体中的稳定性。

J Parenter Drug Assoc. 1979 May-Jun;33(3):107-16.

cis-Dichlorodiammineplatinum(II) stability in aqueous vehicles: an alternate view.顺式二氯二氨合铂（II）在水性载体中的稳定性：另一种观点。

Cancer Treat Rep. 1979 Feb;63(2):229-31.

Stability of sodium ampicillin in aqueous solutions.氨苄西林钠在水溶液中的稳定性。

Am J Hosp Pharm. 1972 Apr;29(4):321-2.

Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.

Am J Hosp Pharm. 1987 Jan;44(1):124-30.

Fat emulsion vehicle for intravenous administration of an aqueous insoluble drug.

Am J Hosp Pharm. 1975 Jun;32(6):582-4.

Some quantitative data on cis-dichlorodiammineplatinum(II) species in solution.溶液中顺式二氯二氨合铂（II）物种的一些定量数据。

Cancer Treat Rep. 1979 Feb;63(2):231-3.

Stability of sodium oxacillin in intravenous solutions.

Am J Hosp Pharm. 1975 Nov;32(11):1130-2.

Effect of vehicle on the stability of sodium aminosalicylate in liquid dosage forms.溶媒对氨基水杨酸钠在液体制剂中稳定性的影响。

Am J Hosp Pharm. 1973 May;30(5):441-3.

Stability of antibiotics in parenteral solutions.

Pediatrics. 1972 Jan;49(1):22-9.

Stability of pediatric liquid dosage forms of ethacrynic acid, indomethacin, methyldopate hydrochloride, prednisone and spironolactone.

Am J Hosp Pharm. 1978 Nov;35(11):1382-5.

引用本文的文献

A Rapid 3-Day Excipient Screening Methodology and its Application in Identifying Chemical Stabilizers for Solid Formulations with Mixed Mechanisms of Degradation.一种快速 3 天辅料筛选方法及其在鉴定具有混合降解机制的固体制剂化学稳定剂中的应用。

AAPS PharmSciTech. 2024 Jan 5;25(1):12. doi: 10.1208/s12249-023-02730-5.

Permeability of the rat bladder to Cisplatinum under different conditions: comparison with Mitomycin C and Adriamycin.

Urol Res. 1983;11(1):39-42. doi: 10.1007/BF00272708.

Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.脂质体作为顺二氨二氯铂（II）的药物载体系统。II. 体内抗肿瘤活性、耐药性诱导、肾毒性及铂分布

Cancer Chemother Pharmacol. 1988;21(4):299-307. doi: 10.1007/BF00264195.

Serum and tissue levels of platinum after cisplatinum instillation of the rat bladder.

Urol Res. 1988;16(2):85-8. doi: 10.1007/BF00261961.

Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.用于体外分析的抗肿瘤药物制剂在制备和储存过程中的稳定性。III. 抗代谢物、微管蛋白结合剂、铂类药物、安吖啶、L-天冬酰胺酶、干扰素、类固醇及其他各类抗肿瘤药物

Cancer Chemother Pharmacol. 1989;23(4):197-207. doi: 10.1007/BF00451642.

Platinum antitumour agents: a review of (bio)analysis.铂类抗肿瘤药物：（生物）分析综述

Pharm Weekbl Sci. 1992 Jun 19;14(3):61-77. doi: 10.1007/BF01962689.

Stability of the new anticancer platinum analogue 1,2-diaminomethyl-cyclobutane-platinum(II)-lactate (lobaplatin; D19466) in intravenous solutions.新型抗癌铂类似物1,2 - 二氨基甲基 - 环丁烷 - 铂（II） - 乳酸盐（乐铂；D19466）在静脉注射液中的稳定性。

Pharm Res. 1992 Jun;9(6):808-11. doi: 10.1023/a:1015815908347.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验